Target intelligence / Profile preview

POU2F3 antisense RNA 1 (POU2F3-AS1)

Target
POU2F3-AS1
Molecular classification
Antisense RNA, Long non-coding RNA (lncRNA)
01

Overview

POU2F3 antisense RNA 1 (POU2F3-AS1) is an antisense long non-coding RNA located within or adjacent to the POU2F3 gene locus. Antisense RNA molecules generally regulate gene expression through sequence complementarity to their sense transcripts, leading to effects on transcription, splicing, mRNA stability, or chromatin state. The canonical gene POU2F3 itself encodes a transcription factor critical in cell lineage differentiation; however, POU2F3-AS1 is a non-protein-coding RNA whose functions currently are inferred and unvalidated in disease or therapeutics. Like other antisense lncRNAs, it may regulate, in cis or trans, the activity of its host gene (POU2F3) or nearby genes, contributing to gene expression patterns relevant for cellular differentiation, potentially cancer, or other physiological or pathological states[1][2][6]. Specific details about its clinical or experimental therapeutic relevance, drug interactions, biomarker status, or direct disease association are lacking in current literature[1][6].

Other names
POU2F3-AS1
02

Mechanism of action

Not established for this molecule; mechanisms for antisense lncRNAs generally include transcriptional interference, chromatin modification, and mRNA stability modulation

03

Biological functions

Regulation of gene expression via cis and trans effectsPotential modulation of chromatin structure or transcriptional activity (general to antisense lncRNAs)
04

Disease associations

Potential involvement in cancer or epigenetic regulation (based on the roles of antisense lncRNAs); specific disease associations for POU2F3-AS1 have not been directly described
05

Safety considerations

None described; therapeutic manipulation of antisense RNAs may pose risks related to off-target gene regulation, but specific concerns for POU2F3-AS1 are not known

Beyond the preview

Go deeper on POU2F3 antisense RNA 1 (POU2F3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POU2F3 antisense RNA 1 (POU2F3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call